Curis (CRIS) to Release Earnings on Tuesday
Curis (NASDAQ:CRIS) will be releasing its Q313 earnings data on Tuesday, November 5th. Analysts expect Curis to post earnings of ($0.01) per share and revenue of $6.44 million for the quarter.
Shares of Curis (NASDAQ:CRIS) remained flat at $3.93 during trading on Monday. 127,529 shares of the company’s stock traded hands. Curis has a 52-week low of $2.66 and a 52-week high of $4.74. The stock’s 50-day moving average is $4.27 and its 200-day moving average is $3.91. The company’s market cap is $321.1 million.
Several analysts have recently commented on the stock. Analysts at Zacks downgraded shares of Curis from an “outperform” rating to a “neutral” rating in a research note to investors on Wednesday, October 9th. They now have a $4.90 price target on the stock. On the ratings front, analysts at Robert W. Baird initiated coverage on shares of Curis in a research note to investors on Tuesday, October 1st. They set an “outperform” rating and a $7.00 price target on the stock. Finally, analysts at Chardan Capital initiated coverage on shares of Curis in a research note to investors on Monday, September 30th. They set a “buy” rating and a $6.00 price target on the stock. Two analysts have rated the stock with a hold rating and three have assigned a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $6.23.
Curis, Inc is a drug discovery and development company that is committed to leveraging signaling pathway drug technologies in seeking to develop next generation network-targeted cancer therapies.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.